These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11535317)

  • 1. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity.
    Lee Y; Eo SK; Rouse RJ; Rouse BT
    Virology; 2003 Jul; 312(1):169-80. PubMed ID: 12890630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic co-transfer of CCR7 ligands enhances immunity and prolongs survival against virulent challenge of pseudorabies virus.
    Han YW; Aleyas AG; George JA; Kim SJ; Kim HK; Yoo DJ; Kang SH; Eo SK
    Immunol Cell Biol; 2009 Jan; 87(1):91-9. PubMed ID: 18794906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge.
    Yan Y; Hu K; Fu M; Deng X; Luo S; Tong L; Guan X; He S; Li C; Jin W; Du T; Zheng Z; Zhang M; Liu Y; Hu Q
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL19 and CCL28 augment mucosal and systemic immune responses to HIV-1 gp140 by mobilizing responsive immunocytes into secondary lymph nodes and mucosal tissue.
    Hu K; Luo S; Tong L; Huang X; Jin W; Huang W; Du T; Yan Y; He S; Griffin GE; Shattock RJ; Hu Q
    J Immunol; 2013 Aug; 191(4):1935-47. PubMed ID: 23858028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7.
    Willimann K; Legler DF; Loetscher M; Roos RS; Delgado MB; Clark-Lewis I; Baggiolini M; Moser B
    Eur J Immunol; 1998 Jun; 28(6):2025-34. PubMed ID: 9645384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
    Westermann J; Nguyen-Hoai T; Baldenhofer G; Höpken UE; Lipp M; Dörken B; Pezzutto A
    Cancer Gene Ther; 2007 Jun; 14(6):523-32. PubMed ID: 17384577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA encoding CCR7 ligands compensate for dysfunctional CD8+ T cell responses by effects on dendritic cells.
    Eo SK; Kumaraguru U; Rouse BT
    J Immunol; 2001 Oct; 167(7):3592-9. PubMed ID: 11564771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
    Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
    J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with beta2-adrenergic agonist.
    Kim SB; Han YW; Rahman MM; Kim SJ; Yoo DJ; Kang SH; Kim K; Eo SK
    Exp Mol Med; 2009 Nov; 41(11):812-23. PubMed ID: 19641376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin JI; Kim JJ; Zhang D; Weiner DB
    Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
    Eo SK; Gierynska M; Kamar AA; Rouse BT
    J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
    Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
    J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.
    Toka FN; Gierynska M; Rouse BT
    J Virol; 2003 Dec; 77(23):12742-52. PubMed ID: 14610196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
    Sin JI; Bagarazzi M; Pachuk C; Weiner DB
    DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
    Toka FN; Rouse BT
    J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR7 signaling inhibits T cell proliferation.
    Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
    J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant.
    Kathuria N; Kraynyak KA; Carnathan D; Betts M; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2012 Nov; 8(11):1607-19. PubMed ID: 23151454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.
    Yoshida R; Nagira M; Kitaura M; Imagawa N; Imai T; Yoshie O
    J Biol Chem; 1998 Mar; 273(12):7118-22. PubMed ID: 9507024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.